Marcin Kortylewski
```
Marcin Kortylewski |
|---|
Marcin Kortylewski is a prominent figure in the field of immunology. He is known for his significant contributions to the understanding of cancer immunotherapy and tumor microenvironment.
Early Life and Education[edit | edit source]
Details about Marcin Kortylewski's early life and education are not available.
Career[edit | edit source]
Kortylewski's career has been focused on researching the interactions between the immune system and cancer cells. His work has shed light on the mechanisms by which tumors evade immune surveillance and has led to the development of novel immunotherapies.
Research[edit | edit source]
Kortylewski's research primarily revolves around the role of myeloid-derived suppressor cells (MDSCs) in promoting tumor growth and suppressing anti-tumor immune responses. His studies have highlighted the potential of targeting MDSCs as a strategy to enhance the efficacy of cancer immunotherapy.
Awards and Recognition[edit | edit source]
Marcin Kortylewski has received several awards and honors for his groundbreaking research in the field of immunology.
Publications[edit | edit source]
Selected publications by Marcin Kortylewski include:
- "Targeting STAT3 in cancer immunotherapy" - Journal of Immunology
- "Myeloid-derived suppressor cells as a therapeutic target for cancer" - Cancer Research
References[edit | edit source]
```
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
